Ask AI

ClinicalThought

Share

Program Content

Activities

  • ASH2025 BsAb MM
    Key Updates on Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma From ASH 2025
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 31, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson